Literature DB >> 21667324

Studies on BVD involving establishment of sentinel calves and assessment of herd immunity in a large dairy farm in Saudi Arabia.

Eltayb Abu Elzein1, Mofeed Alkhalyifa.   

Abstract

Little information is published, so far, regarding bovine viral diarrhea (BVD) in Saudi Arabia and the Gulf region. This study is the first of its kind in the country. Its aim was to explore the BVD situation in a large dairy farm, which has been experiencing reproduction problems suggestive of BVD virus infection, albeit the practice of routine vaccination. The study took two pathways; the first involved establishment of a cohort of sentinel calves so as: (a) to note the BVD virus activity in the farm by following the time lapse and pattern for waning of the maternally derived antibodies and detection of any subsequent seroconversion and (b) to look for any clinical signs suggestive of BVD virus infection in these calves. The second pathway was to assess the level of herd immunity in the different age groups of lactating cows and maiden heifers. The obtained results were discussed, and control strategies were outlined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667324     DOI: 10.1007/s11250-011-9912-3

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  11 in total

1.  An apparently new transmissible disease of cattle.

Authors:  P OLAFSON; A D MacCALLUM; F H FOX
Journal:  Cornell Vet       Date:  1946-07

2.  Quantitation of bovine viral diarrhea virus in embryo transfer flush fluids collected from a persistently infected heifer.

Authors:  K V Brock; D R Redman; M L Vickers; N E Irvine
Journal:  J Vet Diagn Invest       Date:  1991-01       Impact factor: 1.279

3.  Duration of active and colostrum-derived passive antibodies to bovine viral diarrhea virus in calves.

Authors:  M F Coria; A W McClurkin
Journal:  Can J Comp Med       Date:  1978-04

4.  Specific immune tolerance in an apparently healthy bull persistently infected with bovine viral diarrhea virus.

Authors:  M F Coria; A W McClurkin
Journal:  J Am Vet Med Assoc       Date:  1978-02-15       Impact factor: 1.936

5.  Identification of cattle persistently infected with BVDV by ear-notch testing in Saudi Arabia.

Authors:  M A Al-Khaliyfa; E M E Abuelzein; A A Gameel
Journal:  Vet Rec       Date:  2010-10-23       Impact factor: 2.695

6.  Persistent bovine viral diarrhoea virus infection in US beef herds.

Authors:  T E Wittum; D M Grotelueschen; K V Brock; W G Kvasnicka; J G Floyd; C L Kelling; K G Odde
Journal:  Prev Vet Med       Date:  2001-04-13       Impact factor: 2.670

7.  Comparison of ear notch immunohistochemistry, ear notch antigen-capture ELISA, and buffy coat virus isolation for detection of calves persistently infected with bovine viral diarrhea virus.

Authors:  Todd E Cornish; Alberto L van Olphen; Jacqueline L Cavender; Joan M Edwards; Paula T Jaeger; Leslie L Vieyra; Lynn F Woodard; Dan R Miller; Donal O'Toole
Journal:  J Vet Diagn Invest       Date:  2005-03       Impact factor: 1.279

8.  Bovine virus diarrhoea virus, a cause of early pregnancy failure in the cow.

Authors:  U Carlsson; G Fredriksson; S Alenius; H Kindahl
Journal:  Zentralbl Veterinarmed A       Date:  1989-01

9.  Clinical consequences of a bovine virus diarrhoea virus infection in a dairy herd: a longitudinal study.

Authors:  A Moerman; P J Straver; M C de Jong; J Quak; T Baanvinger; J T van Oirschot
Journal:  Vet Q       Date:  1994-07       Impact factor: 3.320

Review 10.  Immunological responses to bovine virus diarrhoea virus infections.

Authors:  C J Howard
Journal:  Rev Sci Tech       Date:  1990-03       Impact factor: 1.181

View more
  1 in total

1.  Seroprevalence and risk factors of bovine viral diarrhoea virus (BVDV) infection in yaks (Bos grunniens) in northwest China.

Authors:  Jian-Gang Ma; Wei Cong; Fu-Heng Zhang; Sheng-Yong Feng; Dong-Hui Zhou; Yi-Ming Wang; Xing-Quan Zhu; Hong Yin; Gui-Xue Hu
Journal:  Trop Anim Health Prod       Date:  2016-08-10       Impact factor: 1.559

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.